| ISA | ALKYLATING-DRUG |
| ANCESTORS | ALKYLATING-DRUG ALL ANTINEOPLASTIC-AGENT DRUG MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL |
| lomustine | definition: alkylating anticancer drug used in the treatment of lung and kidney carcinomas, Hodgkin's and non-Hodgkin's lymphomas and brain tumors. Possible side effects are dose-limiting myelosupression, hair loss, nausea and vomiting and liver, kidney and eye problems. It is taken orally. (en) number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): i_lomust.txt origination date: 04/06/2002 |
| CCNU | definition: see lomustine (en) number: mass part of speech: noun reliability code: 10 term type: acronym |
| CeeNU | definition: see lomustine (en) number: mass part of speech: noun reliability code: 10 term type: abbreviated form of term |
| lomustina | definition: fármaco alquilante antineoplásico, utilizado para el tratamiento de carcinomas de pulmón y riñón, linfomas Hodgkin y no-Hodgkin y tumores cerebrales. Los efectos secundarios más comunes incluyen mielosupresión limitante de dosis, nauseas y vómitos, alopecia así como posibles problemas de hígado, riñón y oculares. Administración intravenosa. (es) gender: feminine number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): e_lomust.txt origination date: 03/06/2002 |